Mutant p53(R175H) promotes cancer initiation in the pancreas by stabilizing HSP70

Pancreatic cancer remains a highly lethal malignancy. We have recently shown that simultaneous expression of Kras and mutant Tp53(R175H) promotes invasive ductal adenocarcinoma from pancreatic ductal cells. We hypothesized specific mutations in TP53 have divergent mechanisms of transforming ductal cells. In order to understand the role of mutant TP53 in transforming pancreatic ductal cells, we used a lentiviral system to express mutant TP53(R175H) and TP53(R273H), two of the most frequently mutated TP53 alleles in pancreatic cancer patients, in immortalized, but not transformed, pancreatic ductal epithelial cells carrying a KRAS mutation (HPNE:KRAS(G12D)). Mutant TP53 expression enhanced colony formation and an RPPA assay results revealed TP53(R175H) uniquely induced HSP70 expression in HPNE:KRAS(G12D) cells. In the context of TP53(R175H) expression; we observed nuclear localization of HSP70. We performed immunoprecipitation experiments to show mutant p53(R175H) binds to HSP70. We also provide evidence mutant p53(R175H) is important for HSP70 stability and, more importantly, HSP70 is required for mutant p53 stability. These data are critical in the context of events leading to cellular transformation in the pancreas.